GO:0019825 oxygen binding: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0019825 oxygen binding is a molecular function defined as binding to oxygen (O2), with cytochrome P450 and cytochrome P450 activity as synonyms.
Oxygen binding underlies oxygen sensing, transport, and enzymatic catalysis, and is central to hypoxia-inducible factor (HIF) regulation.
The VHL tumor suppressor targets HIF-alpha for oxygen-dependent proteolysis, linking oxygen binding to cancer biology.
Prolyl hydroxylation of HIF-alpha is an oxygen-dependent modification that controls VHL-mediated ubiquitylation.
Oxygen as a terminal electron acceptor is fundamental to respiratory energy conservation in bacteria and mitochondria.
Hypoxia response elements (HREs) mediate transcriptional responses to oxygen availability, and lactate can induce a hypoxia-like response.

Description

Oxygen binding (GO:0019825) is a molecular function describing the binding of molecular oxygen (O2) by a protein or molecular complex. This function is essential for biological processes ranging from respiration and oxygen transport to oxygen-dependent enzymatic reactions and cellular oxygen sensing. The QuickGO definition states simply: Binding to oxygen (O2). Synonyms include cytochrome P450 and cytochrome P450 activity, reflecting the historical association of this term with heme-containing monooxygenases that bind oxygen as a substrate. In biomedical research, oxygen binding is most prominently studied in the context of hypoxia signaling, where oxygen availability controls the stability of hypoxia-inducible factor (HIF) subunits. The HIF system exemplifies how a molecular binding event, the binding of oxygen by prolyl hydroxylases, is translated into changes in gene expression, metabolism, and cell survival. Because oxygen binding is mechanistically linked to cancer, ischemia, and metabolic disease, it is a high-value target for functional genomics and CRISPR-based modeling.

oxygen binding At A Glance

GO ID GO:0019825
GO term oxygen binding
Ontology molecular_function
Synonym cytochrome P450; cytochrome P450 activity
Definition Binding to oxygen (O2).
Major function Reversible or catalytic binding of molecular oxygen by proteins, enabling oxygen sensing, transport, and enzymatic oxidation.
Representative proteins HIF prolyl hydroxylases, globins, cytochrome P450 enzymes, terminal oxidases.
Associated process Oxygen-dependent regulation of HIF-alpha stability and hypoxic gene expression.
Disease relevance Cancer, ischemia, and metabolic disorders through HIF signaling and oxygen-dependent proteolysis.

What Is GO:0019825?

GO:0019825 oxygen binding is defined as the molecular function of binding to oxygen (O2). It describes the non-covalent or covalent interaction of a protein with molecular oxygen, without specifying the downstream fate of the bound oxygen. This term is classified under molecular_function in the Gene Ontology and carries the synonyms cytochrome P450 and cytochrome P450 activity. Proteins annotated with this term include globins, heme-containing enzymes, and oxygen-sensing hydroxylases. The function is often studied in the context of oxygen-dependent regulation of HIF, where oxygen binding by prolyl hydroxylases triggers hydroxylation of HIF-alpha and subsequent VHL-mediated degradation.

Why Is oxygen binding Important in Cell Biology?

Oxygen binding is important because it is the molecular event that allows cells to sense and respond to oxygen availability. The HIF pathway depends on oxygen-dependent prolyl hydroxylation of HIF-alpha, which is recognized by the VHL tumor suppressor and leads to proteasomal degradation. When oxygen is limiting, this binding-dependent modification is reduced, HIF-alpha accumulates, and hypoxia response elements drive transcriptional programs that affect angiogenesis, metabolism, and survival. In bacteria, oxygen binding by terminal oxidases enables respiration and energy conservation. Thus, GO:0019825 is a central node connecting molecular oxygen chemistry to physiology and disease.
Oxygen binding by prolyl hydroxylases controls HIF-alpha stability and hypoxic gene expression.
The VHL tumor suppressor recognizes oxygen-dependent modifications on HIF-alpha, linking oxygen binding to cancer.
HIF-1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
Hypoxia response elements mediate transcriptional adaptation to low oxygen.
Lactate can induce a hypoxia-like response, showing crosstalk between metabolism and oxygen signaling.
Oxygen serves as a terminal electron acceptor in bacterial respiration.
Oxygen binding is relevant to brain ischemia and neuronal survival.
Cytochrome P450 enzymes, a synonym of this term, use oxygen binding for oxidative metabolism.
Oxygen-sensing pathways are attractive targets for cancer and ischemia research.
CRISPR models of oxygen-binding proteins enable causal testing of hypoxia-related hypotheses.

Molecular Mechanism of oxygen binding

Oxygen binding by heme and non-heme centers
In simple terms: Proteins grab oxygen using special metal-containing pockets.
Many oxygen-binding proteins use heme iron or non-heme iron centers to coordinate O2. Cytochrome P450 enzymes, which are synonymous with this GO term, are heme-containing monooxygenases that bind oxygen and use it to oxidize substrates. In bacterial respiration, terminal oxidases bind oxygen as the final electron acceptor, enabling energy conservation. These binding events are the first step in oxygen-dependent catalysis and sensing.
Oxygen-dependent prolyl hydroxylation of HIF-alpha
In simple terms: When oxygen is present, a modification marks HIF for destruction.
HIF-alpha is targeted for VHL-mediated destruction by proline hydroxylation, a modification that requires oxygen. Jaakkola et al. showed that HIF-alpha is targeted to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. This oxygen-binding-dependent hydroxylation is the core of oxygen sensing in animal cells.
VHL recognition and proteasomal degradation
In simple terms: The mark left by oxygen is read by a tumor suppressor that destroys HIF.
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Once HIF-alpha is hydroxylated in an oxygen-dependent manner, VHL recognizes the modification and recruits the ubiquitylation machinery, leading to proteasomal degradation. This mechanism ensures that HIF-alpha is rapidly cleared when oxygen is available.
Transcriptional output via hypoxia response elements
In simple terms: When oxygen is low, HIF turns on specific genes.
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Hypoxia response elements (HREs) in target gene promoters mediate transcriptional activation under low oxygen. This output links the molecular function of oxygen binding to physiological adaptation.
Metabolic crosstalk and lactate-induced responses
In simple terms: Metabolites can mimic low oxygen signals.
A lactate-induced response to hypoxia has been described, showing that metabolic signals can intersect with oxygen-sensing pathways. This crosstalk expands the relevance of oxygen binding beyond classical hypoxia and into metabolic regulation.

Key Genes Involved in GO:0019825 oxygen binding

The following genes and proteins are central to oxygen binding (GO:0019825) and its downstream biology, based on the verified literature.
GeneMajor RoleResearch Relevance
HIF1AOxygen-regulated subunit of HIF-1; degraded by VHL under normoxiaCore oxygen-sensing factor; target for hypoxia and cancer studies
EPAS1 (HIF2A)HIF-alpha family member regulated by oxygen-dependent prolyl hydroxylationImplicated in oxygen sensing and tumor biology
VHLTumour suppressor that targets HIF-alpha for oxygen-dependent proteolysisKey E3 ligase component in oxygen sensing; mutated in VHL disease
EGLN1 (PHD2)Prolyl hydroxylase that modifies HIF-alpha in an oxygen-dependent mannerPrimary oxygen sensor; target for modulating HIF stability
EGLN2 (PHD1)Prolyl hydroxylase family member acting on HIF-alphaOxygen-dependent regulator of HIF
EGLN3 (PHD3)Prolyl hydroxylase family member acting on HIF-alphaOxygen-dependent regulator of HIF
ARNT (HIF1B)Basic-helix-loop-helix-PAS partner of HIF-1Required for HIF transcriptional activity
HBBHemoglobin beta subunit; binds oxygen for transportModel for oxygen transport and globin research
HBA1Hemoglobin alpha subunit; binds oxygen for transportModel for oxygen transport and globin research
MBMyoglobin; oxygen-binding protein in muscleModel for oxygen storage and muscle physiology
CYP1A1Cytochrome P450 enzyme; binds oxygen for oxidative metabolismModel for P450-mediated oxygen activation
CYP3A4Cytochrome P450 enzyme; binds oxygen for oxidative metabolismModel for drug metabolism and oxygen binding
CYB5ACytochrome b5; involved in electron transfer and oxygen-related redox reactionsModel for redox and oxygen-binding studies
COX1 (MT-CO1)Terminal oxidase subunit; binds oxygen as electron acceptorModel for respiratory oxygen binding
COX2 (MT-CO2)Terminal oxidase subunit; binds oxygen as electron acceptorModel for respiratory oxygen binding
LDHALactate dehydrogenase A; linked to lactate-induced hypoxia responseModel for metabolic crosstalk with oxygen sensing
SLC2A1 (GLUT1)Hypoxia-inducible glucose transporter; downstream of HREReadout of HIF transcriptional activity
VEGFAHypoxia-inducible angiogenic factor; downstream of HREReadout of HIF-driven angiogenesis

How Is oxygen binding Regulated?

Oxygen binding and its downstream effects are regulated primarily by oxygen availability itself. Under normoxia, prolyl hydroxylases modify HIF-alpha, enabling VHL-mediated ubiquitylation and proteasomal degradation. Under hypoxia, this modification is reduced, HIF-alpha accumulates, and hypoxia response elements drive transcription. Metabolic signals such as lactate can also induce a hypoxia-like response, indicating additional layers of regulation. In bacteria, oxygen availability controls respiratory gene expression and the use of oxygen as a terminal electron acceptor.

oxygen binding and Human Disease

GeneDisease / BiologyPotential Experimental Model
VHLVon Hippel-Lindau disease; renal cell carcinomaVHL knockout or point-mutation cell lines to stabilize HIF
HIF1AHypoxia adaptation in cancer and ischemiaHIF1A knockout and hypoxia-response reporter lines
EGLN1 (PHD2)Oxygen sensing; tumor suppressionEGLN1 knockout to mimic hypoxia at normoxia
EPAS1 (HIF2A)Tumor angiogenesis and metabolismEPAS1 overexpression or knock-in models
LDHALactate-induced hypoxia responseLDHA knockout under hypoxia and lactate treatment
Cancer and VHL disease
The oxygen-dependent degradation of HIF-alpha is mediated by VHL, a tumour suppressor. Loss of VHL function leads to constitutive HIF stabilization and is associated with von Hippel-Lindau disease and clear cell renal cell carcinoma. Prolyl hydroxylation of HIF-alpha is the oxygen-dependent mark recognized by VHL.
Ischemia and brain injury
When the brain yearns for oxygen, hypoxia triggers neuronal stress responses that can lead to injury. Oxygen-sensing pathways involving HIF and its targets are central to ischemic preconditioning and post-ischemic adaptation.
Metabolic and lactate-driven responses
A lactate-induced response to hypoxia links glycolytic metabolism to oxygen-sensing pathways. This crosstalk is relevant to cancer metabolism and exercise physiology, where oxygen availability and lactate production are intertwined.

From oxygen binding-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of VHL stabilize HIF under normoxia?VHL knockout cell line
Does prolyl hydroxylase inhibition mimic hypoxia?EGLN1/2/3 knockout or point-mutation models
Is HIF-1 transcriptional activity oxygen-dependent?HRE-luciferase reporter with HIF1A knockout
Does lactate induce a hypoxia-like response?LDHA knockout with lactate treatment
Is oxygen binding by cytochrome P450 required for substrate oxidation?CYP point-mutation or knockout models
Does oxygen availability control bacterial respiration?Terminal oxidase knockout in bacterial models

How to Study the oxygen binding Process

MethodWhat It MeasuresTypical Application
Western blotHIF-alpha protein levelsOxygen-dependent degradation
HRE-luciferase reporterHIF transcriptional activityHypoxia response element function
Prolyl hydroxylation immunoblotHIF-alpha modification statusOxygen-dependent hydroxylation
Lactate assayGlycolytic outputLactate-induced hypoxia response
Oxygen consumption assayRespiratory activityBacterial terminal oxidase function
qPCR for HIF targetsVEGFA, SLC2A1 expressionHIF pathway activation
CRISPR knockout screeningGene requirement for hypoxia survivalOxygen-binding gene discovery
Hypoxia and HIF stability assays
Western blotting for HIF-alpha under normoxia and hypoxia is a standard method to assess oxygen-dependent degradation. Prolyl hydroxylation status can be probed with modification-specific antibodies.
Transcriptional reporter assays
Hypoxia response element (HRE) luciferase reporters measure HIF transcriptional activity in response to oxygen tension. These assays are useful for testing genetic perturbations of oxygen-binding proteins.
Metabolic and lactate measurements
Lactate production and glycolytic flux can be measured to assess crosstalk between metabolism and oxygen sensing. Such readouts complement HIF target gene analysis.
Microbial respiration assays
Oxygen consumption and terminal oxidase activity assays in bacteria reveal the role of oxygen as an electron acceptor. These methods are applicable to cytochrome and oxidase studies.

How CRISPR Can Be Used to Study GO:0019825 oxygen binding

Knockout

CRISPR knockout of VHL, HIF1A, or EGLN genes enables causal testing of oxygen-sensing mechanisms. For example, VHL knockout stabilizes HIF-alpha under normoxia, mimicking hypoxia.

Point Mutation

Point mutations in prolyl hydroxylation sites of HIF-alpha or in the catalytic domain of EGLN enzymes can dissect oxygen-dependent recognition by VHL. Such models are valuable for separating binding from downstream effects.

Knock-in

Knock-in of tagged HIF1A or EGLN alleles allows tracking of oxygen-dependent modification and localization in live cells. Tagged knock-ins support proteomic and imaging studies.

Overexpression

Overexpression of HIF1A, EPAS1, or cytochrome P450 enzymes can amplify oxygen-binding-dependent phenotypes and facilitate biochemical assays. Overexpression models are useful for drug screening and pathway mapping.

How EDITGENE Supports oxygen binding Research

Researchers studying oxygen binding-related genes often need to determine whether a candidate gene is causally involved in oxygen sensing, HIF stabilization, or metabolic adaptation. CRISPR-based models provide the specificity required to move from correlation to causation, and EDITGENE offers a comprehensive platform for generating and validating such models.
Contact EDITGENE today to design your custom CRISPR model for oxygen binding research.

Frequently Asked Questions About oxygen binding

GO:0019825 is a Gene Ontology molecular function term defined as binding to oxygen (O2), with synonyms cytochrome P450 and cytochrome P450 activity.
Key genes include HIF1A, EPAS1, VHL, EGLN1/2/3, HBB, HBA1, MB, and cytochrome P450 genes such as CYP1A1 and CYP3A4.
Oxygen binding by prolyl hydroxylases modifies HIF-alpha, enabling VHL-mediated ubiquitylation and proteasomal degradation.
VHL is a tumour suppressor that targets hypoxia-inducible factors for oxygen-dependent proteolysis.
Hypoxia response elements (HREs) are DNA sequences that mediate transcriptional activation by HIF under low oxygen.
Yes, a lactate-induced response to hypoxia has been described, linking metabolism to oxygen-sensing pathways.
Oxygen-dependent degradation of HIF-alpha is mediated by VHL, and loss of VHL leads to HIF stabilization associated with cancer.
Common methods include HIF-alpha western blotting, HRE-luciferase reporters, prolyl hydroxylation immunoblots, and oxygen consumption assays.
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of oxygen-binding genes in hypoxia and cancer research.
Yes, when the brain yearns for oxygen, hypoxia triggers neuronal stress responses relevant to ischemia.

Conclusion

GO:0019825 oxygen binding is a fundamental molecular function that connects oxygen chemistry to cellular signaling, metabolism, and disease. The HIF-VHL-prolyl hydroxylase axis provides a paradigm for how oxygen binding controls protein stability and transcription. Understanding this term is essential for cancer, ischemia, and metabolic research, and CRISPR-based models offer powerful tools to dissect its mechanisms.

References

  1. 1. Maxwell PH et al.. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.. Nature 399(6733):271-5 PMID: 10353251
  2. 2. Borisov VB et al.. 2015. Oxygen as Acceptor.. EcoSal Plus 6(2) PMID: 26734697
  3. 3. Leu T et al.. 2019. When the Brain Yearns for Oxygen.. Neurosignals 27(1):50-61 PMID: 31860206
  4. 4. Ivan M et al.. 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.. Science 292(5516):464-8 PMID: 11292862
  5. 5. Wang GL et al.. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.. Proc Natl Acad Sci U S A 92(12):5510-4 PMID: 7539918
  6. 6. Lee DC et al.. 2015. A lactate-induced response to hypoxia.. Cell 161(3):595-609 PMID: 25892225
  7. 7. Jaakkola P et al.. 2001. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.. Science 292(5516):468-72 PMID: 11292861
  8. 8. O'Rourke JF et al.. 1997. Hypoxia response elements.. Oncol Res 9(6-7):327-32 PMID: 9406238
Contact Us
*
*
*
*
How did you hear about us: